Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,984,527
+$18,907,196 QoQ
Shares Held
820,078
+147.2% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#40
of 712 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Mar 31, 2025CallValue
$11,092,000
CallShares
200,000
PutValue
$6,377,900
PutShares
115,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. SNY ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
This page
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in SNY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,984,527 | 820,078 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $16,077,331 | 331,765 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,432,564 | 369,334 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $11,092,000 | 200,000 | Call | Defined | 2025-07-21 | |
| 2025-03-31 | $6,377,900 | 115,000 | Put | Defined | 2025-07-21 | |
| 2024-12-31 | $45,849,801 | 950,649 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,122,096 | 88,879 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,261,397 | 211,488 | Shares | Defined | 2024-09-16 | |
| 2023-12-31 | $38,108,099 | 766,300 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $24,215,000 | 500,000 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $28,515,000 | 750,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $65,690,081 | 1,727,777 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,808,679 | 315,984 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $68,057,895 | 1,325,631 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $90,906,450 | 1,814,500 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $120,925,384 | 2,508,305 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $74,231,063 | 1,409,629 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $52,299,004 | 1,057,400 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $49,318,850 | 1,015,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $36,565,100 | 728,824 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $43,022,898 | 842,760 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,264,600 | 555,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||